Why Companies Choose Biotech Newswire

Biotech Newswire is a specialized global PR distribution service for biotech, pharma, medtech, and life science companies. We deliver your press release directly to relevant trade media, and thus investors, potential partners and new customers ensuring your press release reaches the audiences that matter. The distribution is 100% industry-specific, irrelevant media outlets such as TV, radio, daily newspapers and financial media are not included.

What sets us apart:

• Unrivaled reach across biotech, pharma, medtech and life sciences trade media (40% U.S., 40% Europe, 20% Rest of World)
• Many vertical channels for highly targeted distribution e.g. Clinical Trials, Oncology, Biomanufacturing, Lab & Research etc.
• Targeted social media visibility reaches 250,000+ biotech professionals through X and LinkedIn
• Affordable, transparent pricing with no word limits and fee-for-service pricing
• Press releases are optimized for AI discovery
• Detailed Post-Release Reports showing real trade media engagement
• Trusted for 25+ years and built by PhD-level scientists with a strong service mindset

Bottom line

If your goal is to reach the trade media, investors, potential partners and new customers - quickly, globally, and without overpaying - Biotech Newswire is the most efficient and cost-effective solution.